financetom
Business
financetom
/
Business
/
Uber CFO to step down in most senior executive exit since IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uber CFO to step down in most senior executive exit since IPO
Jul 10, 2023 9:50 PM

Uber Technologies Inc Chief Financial Officer Nelson Chai is planning to leave the ride-hailing company, according to people familiar with the matter, marking the most significant executive departure since the company went public in 2019.

Share Market Live

NSE

Chai informed Chief Executive Officer Dara Khosrowshahi of his intentions to move on, though a decision on timing hasn’t been made, the people said, asking not to be named discussing non-public information.

“Over the past five years, Nelson has been essential to putting Uber on secure financial footing, steering the company from billions of dollars in losses,” to improved earnings, strong free cash flow and heading toward an operating profit, an Uber spokesman said in a statement. “We are not going to comment on any executive’s potential career decisions during a quiet period.”

Chai’s pending departure caps a nearly five-year tenure for the financial-industry veteran that has included important milestones. After being tapped in 2018 by Khosrowshahi to guide Uber through its initial public offering and fix its balance sheet, the 58-year-old was tasked with bringing Wall Street discipline to a freewheeling tech company that was blowing through startup capital to fund explosive growth. Uber had been operating without a CFO for more than three years until Chai came on board.

Chai oversaw some of Uber’s biggest highs and lows as a public company. San Francisco-based Uber made several multibillion-dollar deals, like the $2.65 billion acquisition of Postmates in 2020 and logistics operator Transplace for $2.25 billion the following year, purchases that helped Uber diversify beyond rides. When the pandemic decimated demand for ride-hailing, Uber’s bookings fell by as much as 80 percent and the company cut more than 6,000 employees.

The following year, Chai steered Uber to its first-ever quarter of positive adjusted Ebitda. While the metric strips out some expenses, it served as a strong signal to investors that Uber was moving past its growth-at-all-costs phase.

Uber generated adjusted Ebitda of $186 million in 2022. While the company has yet to post an annual profit on a generally accepted accounting principles basis, Chai and Khosrowshahi have signaled that’s the next goal.

Ratings firm Moody’s Investors Service lifted the company’s credit grade earlier this year, citing substantial improvements in profitability and cash flow generation that it expects to be sustained.

Before Uber, Chai had been a longtime lieutenant of Wall Street veteran John Thain — the former top-ranking executive at Goldman Sachs Group Inc. Chai later went on to take senior roles at the New York Stock Exchange, Merrill Lynch and CIT Group, crossing paths again with Thain.

At Merrill Lynch, Chai and Thain helped the bank weather the 2008 financial crisis, selling the firm to Bank of America Corp. in what was seen as a coup to avoid a possible collapse. The pair left soon after the deal, only to be reunited at commercial lender CIT Group.

Right before he joined Uber, Chai was CEO of insurance company Warranty Group Inc., which was backed by private equity giant TPG before its sale to Assurant Inc.

Also Read: Startup investors reluctant to back high burn businesses, says expert

First Published:Jul 11, 2023 6:50 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bxp Insider Sold Shares Worth $1,621,225, According to a Recent SEC Filing
Bxp Insider Sold Shares Worth $1,621,225, According to a Recent SEC Filing
Sep 11, 2024
12:22 PM EDT, 09/10/2024 (MT Newswires) -- Raymond A Ritchey, Senior Executive Vice President, on September 09, 2024, sold 21,835 shares in Bxp (BXP) for $1,621,225. Following the Form 4 filing with the SEC, Ritchey has control over a total of 14,150 shares of the company, with 14,150 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1037540/000124699124000297/xslF345X05/wk-form4_1725984937.xml Price: 73.50, Change: -0.80, Percent Change: -1.08...
QUOTES-Fed's Barr unveils sweeping bank capital plan revisions after pushback, delays
QUOTES-Fed's Barr unveils sweeping bank capital plan revisions after pushback, delays
Sep 11, 2024
NEW YORK, Sept 10 (Reuters) - The Federal Reserve's regulatory chief on Tuesday outlined a sweeping overhaul easing two major draft bank capital rules following intense industry opposition that delayed the projects and sparked divisions among the top federal banking regulators. Shares of major U.S. banks fell after Fed Vice Chair for Supervision Michael Barr unveiled the plan for the...
Brookfield Plans To Invest Up To $1.1B in eFuels: Details
Brookfield Plans To Invest Up To $1.1B in eFuels: Details
Sep 10, 2024
Brookfield Asset Management Inc shares are trading lower on Tuesday. The company disclosed a strategic funding partnership with Infinium to invest up to $1.1 billion to advance eFuels production. As per the deal, Brookfield will invest more than $200 million in Infinium and its Project Roadrunner in West Texas, with up to an additional $850 million for other global Infinium eFuels...
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
Sep 11, 2024
Sept 10 (Reuters) - UnitedHealth Group ( UNH ) said on Tuesday it will remove AbbVie's ( ABBV ) blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend less expensive biosimilar versions of the medicine instead. UnitedHealth ( UNH ) said Amgen's ( AMGN ) Amjevita will...
Copyright 2023-2025 - www.financetom.com All Rights Reserved